We are disappointed not able recommend everolimus second

However, we have to ensure that the money available to the NHS is used to best effect, particularly when NHS funds, like the rest of the public sector, is under considerable financial pressure.

The decision was criticised by advocacy groups, who said it was another disappointing blow after NICE last year rebuffed three other drugs for kidney cancer patients.

Once again NICE has disappointed the thousands of kidney cancer sufferers in the UK by not approving everolimus, a drug which gives terminal kidney cancer patients and their families some hope, said Nick Turkentine of the James Whale Fund for Kidney Cancer.

NICE has ruled that only Pfizers cancer drug Sutent will be reimbursed for kidney cancer patients on the NHS, with Roches Avastin, Bayers Nexavar and Pfizers Torisel also rejected as not cost-effective.

Reporting by Kate Kelland, editing by Elaine Hardcastle source

Comments

• Information

  National Library of Medicine
  Health and Human Services
  Pub Med Journals
  World Health Organization

• Fields

  • Allergy
  • Birth
  • Bone
  • Brain
  • Cancer
  • Diabetes
  • Drug
  • FDA
  • Food
  • Heart
  • Lung
  • Obesity
  • Organ
  • Public Health
  • Vaccine
  • Virus

• Topics

  • Possible reasons salsa and guacamole can pose risk
  • Women can take five years aromatase inhibitor therapy
  • Screening all children identify number children
  • Glaxo is conducting a randomized
  • I more optimistic about aids vaccine point time have been
  • We make new neurons every day in our brain
  • Unlike other food allergieswhich might disappear kids grow
  • For many patients in united states
  • We are encouraged significant increase colon cancer
  • A major risk is birds infect pigs
  • Because pounds due excess body fatrather larger bones
  • The study shows even middle aged men need advice about
  • It also opens potential new ways finding and developing
  • If can identify people who are particularly high risk
  • We are disappointed not able recommend everolimus second

• Informative Sites